Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online


             
 

Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.

Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.

Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.

Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.

Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.



NAVIGATION


         

 

An artificial pancreas has for the first time shown it can keep even overnight blood glucose levels normal in a small group of pregnant women with Type 1 diabetes, raising hopes that the new development will significantly reduce stillbirths, abnormalities, and deaths associated with this type of diabetes…

 

XYTOS (the “Company”) (OTC: XYTS) is excited to announce their Cancer Diagnostic Fluorescent Scanning Technique. The XYTOS procedure is a major achievement in the fight against cancer. XYTOS expects that their fluorescent scanning technique will soon become the standard for diagnosing Breast and Skin Cancer…

 

Light, or photodynamic, therapy can help preserve the voice and vocal cord function for patients with early stage laryngeal (voice box) cancer, according to a study from Henry Ford Hospital in Detroit…

 

Each year, approximately 150,000 Canadians have a transient ischemic attack (TIA), sometimes known as a mini-stroke. New research published today in Stroke, the journal of the American Heart Association shows these attacks may not be transient at all. They in fact create lasting damage to the brain. The stroke research team, led by Dr…

 

Protagen AG, a specialist for GMP-compliant protein analysis and in-vitro diagnostics is presenting at the Personalized Medicine and Diagnostics Europe Congress in London. Dr. Stefan Mullner, CEO of Protagen AG will discuss the latest achievements in personalized medicine together with an expert panel of representatives from pharma, biotech and diagnostic…

 

What sounds like science fiction is actually possible: thanks to magnetic stimulation, the activity of certain brain nerve cells can be deliberately influenced. What happens in the brain in this context has been unclear up to now. Medical experts from Bochum under the leadership of Prof. Dr…

 

The suit alleges that Guidant, a subsidiary of Boston Scientific Corp., knowingly sold defective defibrillators. The Wall Street Journal: Justice Department Files Suit Over Guidant DefibrillatorsThe U.S. Justice Department on Thursday filed a civil lawsuit against Boston Scientific Corp…

 

The Welch Foundation has awarded its prestigious Hackerman Award to Rice University scientist Jason Hafner ‘96, who was named this year’s “rising star” for his innovative chemical research…

 

Continuing a stream of recent advancements for stabilization of the spine, Medtronic, Inc. (NYSE: MDT) announced both the release of its CD HORIZON® SOLERA™ Spinal System in the U.S. and a limited market release in Japan…

 

US researchers have made a robotic version of an Amazonian fish that can move from swimming forward and backward to vertically almost instanteously, as a result of which they hope to improve our understanding how the nervous system sends messages throughout the body to make it move…




January 2011
Mon Tue Wed Thu Fri Sat Sun
« Dec   Feb »
 12
3456789
10111213141516
17181920212223
24252627282930
31